MedTrace Logo

Effects of Neuromuscular Training With K-tape in Footballer With Ankle Sprain

NCT06198270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-01-30

No results posted yet for this study

Summary

This randomized controlled trial, conducted at the Pakistan Sports Board in Lahore from March to August 2023, investigates the impact of neuromuscular training with K-Tape on pain, range of motion, and balance in footballers with grade I and II ankle sprains. A total of 30 male participants aged 18-30, engaged in sports for at least one year with weekly training durations of 15-20 hours, are included in the study through a non-probability convenient sampling technique. The participants are divided into two groups: Group A (Control) receiving closed-chain exercises and Group B (Experimental) undergoing neuromuscular training with K-Tape. Data collection utilizes the Numeric Pain Rating Scale (NPRS) for pain, the Star Excursion Balance Test for dynamic balance, Foot and Ankle Ability Measure (FAAM)-Sport Subscale, and a goniometer for range of motion. Participants undergo three sessions of treatment per week for four weeks. The collected data will be analyzed using SPSS version 25, aiming to provide insights into the efficacy of neuromuscular training with K-Tape as a rehabilitation strategy for ankle sprains in footballers.

Conditions

  • Ankle Sprains
  • Proprioception
  • Pain
  • Balanced

Interventions

OTHER

Closed Kinetic Chain Exercise

Closed chain exercise plan of 5 exercises, 10reps x 3sets of each, 3 days in a week for 4-weeks, all values measured before and after 4-weeks.

OTHER

Neuromuscular Training with K Tape

Neuromuscular training plan of 5 exercises, 10reps x 3sets of each, 3 days in a week, for 4-weeks, all values measured before and after 4-weeks. Just After the session k-tape applied.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Aamir Gul Memon, MS-SPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-10
Primary Completion
2023-09-10
Completion
2023-10-01

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06198270 on ClinicalTrials.gov